Retinow
Retinow is a health technology company focused on developing AI-powered solutions for early detection and diagnosis of eye diseases. They have developed a portable fundus camera integrated with AI to assist primary healthcare providers in identifying conditions like dry eye, macular degeneration, glaucoma, and diabetic retinopathy. Their technology aims to improve accessibility to eye health screenings, reduce the burden on specialists, and prevent vision loss. The company was founded in 2019 and has received support from TÜBİTAK, a Turkish science and technology research council. Their business model appears to be centered around providing innovative technological solutions in the healthcare sector.
Retinow
Retinow is a health technology company focused on developing AI-powered solutions for early detection and diagnosis of eye diseases. They have developed a portable fundus camera integrated with AI to assist primary healthcare providers in identifying conditions like dry eye, macular degeneration, glaucoma, and diabetic retinopathy. Their technology aims to improve accessibility to eye health screenings, reduce the burden on specialists, and prevent vision loss. The company was founded in 2019 and has received support from TÜBİTAK, a Turkish science and technology research council. Their business model appears to be centered around providing innovative technological solutions in the healthcare sector.
TL;DR
Product: Portable non-mydriatic fundus camera plus cloud-based AI for retinal screening
Clinical targets: Diabetic retinopathy, glaucoma, age-related macular degeneration, dry eye
Founded: 2019 (founding/incorporation date also listed externally as Jan 16, 2020)
Location: Ankara, Turkey
Support / funding signals: TÜBİTAK 1507 support; equity crowdfunding reported (June 2022)
Company Overview
Problem Domain
Early detection and triage of retinal diseases to expand screening access and enable timely specialist referral.
Founded
2019
Industry
Health technology / Medical devices
Tech Stack
Funding Track Record
Equity crowdfunding round reported June 2022; external profiles name Fonbulucu and Ankara Development Agency as investors.
Technology/project support awarded under TÜBİTAK 1507 to expand device capabilities.
Investor Signal
“Received TÜBİTAK 1507 program support; reported equity crowdfunding investors include Fonbulucu and Ankara Development Agency”